Annual Review of Medicine

Papers
(The TQCC of Annual Review of Medicine is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Phage Therapy for Antibiotic-Resistant Bacterial Infections166
The Gut–Brain Axis140
mRNA Vaccines in the COVID-19 Pandemic and Beyond107
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment85
Hepatocellular Carcinoma Immunotherapy77
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review72
Engineering IL-2 to Give New Life to T Cell Immunotherapy65
Hepcidin and Iron in Health and Disease55
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines50
Diagnosis and Treatment of Helicobacter pylori Infection49
The Gut Microbiome and Inflammatory Bowel Diseases47
COVID-19 and Diabetes43
Direct-to-Consumer Genetic Testing: Value and Risk42
New Therapeutics for Ulcerative Colitis42
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies41
Hematopoietic Stem Cell Transplantation for Autoimmune Disease40
Therapeutics Targeting Mutant KRAS37
New Therapeutics for Hepatitis B: The Road to Cure37
Synchronizing Brain Rhythms to Improve Cognition37
Aspirin in the Prevention of Colorectal Neoplasia36
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches35
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities35
COVID-19: Challenges of Viral Variants35
COVID-19 Vaccines: Adenoviral Vectors35
Cardiovascular Effects of Particulate Air Pollution35
Post-COVID-19 Condition34
COVID-19: Inflammatory Profile34
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression33
Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity31
Advances in Chronic Obstructive Pulmonary Disease28
Clinical Perspectives on IgG4-Related Disease and Its Classification28
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone27
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy27
Cytokine Storm Syndrome26
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches25
0.014125823974609